EDITORIAL
Published on 08 Jul 2024
Editorial: Precision therapy and biomarkers in head and neck squamous cell carcinoma
doi 10.3389/fonc.2024.1442630
- 469 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Precision Therapy and Biomarkers in Head and Neck Squamous Cell Carcinoma
Precision Therapy and Biomarkers in Head and Neck Squamous Cell Carcinoma
3,222
Total downloads
10k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 28 Mar 2024
Case report: Efficacy of icotinib treatment in lung adenocarcinoma with esophageal squamous cell carcinoma: a rare case of double primary malignant tumors
doi 10.3389/fmed.2024.1266062
- 694 views
ORIGINAL RESEARCH
Published on 03 Jan 2024
TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion
doi 10.3389/fimmu.2023.1290839
- 1,768 views
- 2 citations
REVIEW
Published on 13 Dec 2023
Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck
doi 10.3389/fonc.2023.1310106
- 1,461 views
- 2 citations
ORIGINAL RESEARCH
Published on 23 Oct 2023
Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors
doi 10.3389/fonc.2023.1276009
- 1,438 views
- 6 citations
ORIGINAL RESEARCH
Published on 24 Aug 2023
A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation
doi 10.3389/fimmu.2023.1190678
- 1,777 views
- 2 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 10kTopic views
- 6,167Article views
- 3,222Article downloads